OVB — Hydrogel Spacer Class II

FDA Device Classification

Classification Details

Product Code
OVB
Device Class
Class II
Regulation Number
892.5725
Submission Type
Review Panel
RA
Medical Specialty
Radiology
Implant
No

Definition

The perirectal spacer is intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of the perirectal spacer to reduce the radiation dose delivered to the anterior rectum. The perirectal spacer is composed of biodegradable material and maintains space for the entire course of prostate radiotherapy treatment and is completely absorbed by the patient’s body over time.

Recent 510(k) Clearances

K-NumberApplicantDevice NameDate
K260119boston scientific corporationSpaceOAR Vue System (SV-2101)February 10, 2026
K222972bioprotectBioProtect Balloon Implant™ SystemAugust 25, 2023
K220641palette life sciencesBarrigel Injectable GelMay 26, 2022
K202224boston scientific corporationSpaceOAR SystemAugust 28, 2020
K182971augmenixSpaceOAR Vue HydrogelJuly 19, 2019
K181465augmenixSpaceOAR SystemJune 25, 2018
DEN140030augmenixSpaceOAR SystemApril 1, 2015